As the number of people infected with the new coronavirus increases again in India, the framework for fair distribution of vaccines led by WHO = World Health Organization is expected to delay the supply of vaccines such as AstraZeneca manufactured in India. I made it clear.
In India, the number of people infected with the new coronavirus, which had been on a downward trend, has increased again since the end of last month, and the number of people infected on the 25th was more than 53,000.
Under these circumstances, the COVAX Facility, which aims for fair distribution of vaccines led by WHO and others, announced on the 25th about the supply of vaccines such as AstraZeneca manufactured by the major Indian pharmaceutical company Serum Institute of India. , Has revealed that there will be a delay from this month to next month.
Regarding the reason, COVAX points out that the demand for vaccines is increasing in India and will continue to cooperate with the Indian government to receive the vaccine.
On the other hand, it has not disclosed the specific outlook for the delay.
COVAX plans to supply 337.2 million doses of vaccine to 145 countries and regions by the end of June, of which more than 70%, 240 million doses, will be "Serum Institute of India". Relying on vaccines produced by the company, there is concern that this will lead to significant delays in distribution.